Purpose: This quality improvement project will evaluate the use of an educational intervention focusing on two therapeutic communication techniques and their effects on provider and staff self-efficacy towards HPV vaccine recommendationsBackground: HPV-associated diseases and cancers continue to inflict a major burden in the United States. FDA-approved vaccines have been available since 2006 and can prevent over 90 percent of related cancers. Contrary to well-established guidelines and a highly efficacious vaccine, HPV vaccination remains well below the Healthy People 2030 goal of 80%. Strong provider recommendation is the greatest predictor of vaccine uptake, yet inconsistent recommendations are still at the forefront of HPV vaccine practi...
Human Papilloma Virus (HPV) is an insidious and nearly ubiquitous sexually transmitted infection (ST...
The current HPV vaccine uptake rate is not on track to achieve the Healthy People 2020 goal of 80%, ...
The HPV vaccine is effective in preventing HPV-related cancers. Vaccination rates are low in women a...
: To evaluate the effect of a multi-component intervention including communication training on provi...
Background: Human papillomavirus (HPV) is the most commonly sexually transmitted infection in the U...
Problem statement: The Human Papillomavirus (HPV) vaccine protects against carcinogenic strains of H...
Background and objectivesHuman papillomavirus (HPV) vaccination rates lag behind vaccination rates f...
Background: Human Papillomavirus (HPV) infections and associated cancers are growing at an alarming...
Objective: Adding to the literature on the development and evaluation of interventions to increase H...
Background:Human Papillomavirus (HPV) vaccination is an effective method for preventing 9 types of H...
Human papilloma virus (HPV) vaccine was developed to reduce HPV-attributable cancers, external genit...
An estimated 85% of unvaccinated sexually active individuals will acquire Human Papillomavirus (HPV)...
The aim of this study was to design, develop, and evaluate the feasibility of a theory- and evidence...
Abstract Introduction: Human Papillomavirus (HPV) causes 32,500 new cancers and roughly 14 million ...
abstract: Human papillomavirus (HPV) is a prevalent sexually transmitted infection that affects many...
Human Papilloma Virus (HPV) is an insidious and nearly ubiquitous sexually transmitted infection (ST...
The current HPV vaccine uptake rate is not on track to achieve the Healthy People 2020 goal of 80%, ...
The HPV vaccine is effective in preventing HPV-related cancers. Vaccination rates are low in women a...
: To evaluate the effect of a multi-component intervention including communication training on provi...
Background: Human papillomavirus (HPV) is the most commonly sexually transmitted infection in the U...
Problem statement: The Human Papillomavirus (HPV) vaccine protects against carcinogenic strains of H...
Background and objectivesHuman papillomavirus (HPV) vaccination rates lag behind vaccination rates f...
Background: Human Papillomavirus (HPV) infections and associated cancers are growing at an alarming...
Objective: Adding to the literature on the development and evaluation of interventions to increase H...
Background:Human Papillomavirus (HPV) vaccination is an effective method for preventing 9 types of H...
Human papilloma virus (HPV) vaccine was developed to reduce HPV-attributable cancers, external genit...
An estimated 85% of unvaccinated sexually active individuals will acquire Human Papillomavirus (HPV)...
The aim of this study was to design, develop, and evaluate the feasibility of a theory- and evidence...
Abstract Introduction: Human Papillomavirus (HPV) causes 32,500 new cancers and roughly 14 million ...
abstract: Human papillomavirus (HPV) is a prevalent sexually transmitted infection that affects many...
Human Papilloma Virus (HPV) is an insidious and nearly ubiquitous sexually transmitted infection (ST...
The current HPV vaccine uptake rate is not on track to achieve the Healthy People 2020 goal of 80%, ...
The HPV vaccine is effective in preventing HPV-related cancers. Vaccination rates are low in women a...